Literature DB >> 1846240

Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.

O Matsui1, M Kadoya, T Kameyama, J Yoshikawa, T Takashima, Y Nakanuma, M Unoura, K Kobayashi, R Izumi, M Ida.   

Abstract

The blood supplies of nodular lesions associated with liver cirrhosis were analyzed in vivo with various imaging modalities. The portal blood supply was evaluated with computed tomography (CT) during arterial portography (CTAP); the arterial blood supply was evaluated with hepatic angiography, CT angiography, CT following intraarterial injection of iodized oil, or ultrasound following intraarterial injection of carbon dioxide microbubbles. A total of 84 surgically confirmed hepatocellular carcinomas (HCCs) (less than or equal to 3 cm) and 25 areas of adenomatous hyperplasia (AH) were included in the study. At CTAP, a portal blood supply was seen in 96% of cases of AH and only 6% of HCCs (chi 2, P less than .005). In contrast, an arterial supply greater than that of the surrounding liver was verified in 94% of the HCCs and only 4% of the cases of AH (chi 2, P less than .005). The blood supply of areas of AH with atypical hepatocytes and the blood supply of well-differentiated HCCs (Edmondson grade 1) tended to be intermediate between that of AH without atypia and that of HCC that was Edmondson and Steiner grade 2 or greater. Evaluation of the blood supply of the nodular lesions associated with liver cirrhosis is considered to be useful in the differential diagnosis and treatment of early-stage HCC.

Entities:  

Mesh:

Year:  1991        PMID: 1846240     DOI: 10.1148/radiology.178.2.1846240

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  91 in total

1.  Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma.

Authors:  A Nakayama; H Imamura; Y Matsuyama; H Kitamura; S Miwa; A Kobayashi; S Miyagawa ; S Kawasaki
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

Review 2.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology.

Authors:  Nobuyoshi Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-06       Impact factor: 3.402

3.  Computed tomography-guided transarterial chemoembolization as the initial therapy for hepatocellular carcinoma: experience of 75 cases in a single institute.

Authors:  Yoichi Okada; Hiroyasu Ina; Kazunori Kubota; Yoshiro Himeno; Toshihiko Wakita; Isamu Ohashi; Naoya Gomi; Tetsuo Yoshida; Sunao Mae; Tetsuya Irie
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

4.  Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.

Authors:  Carlos Nicolau; Violeta Catalá; Ramón Vilana; Rosa Gilabert; Luis Bianchi; Manel Solé; Mario Pagés; Concepció Brú
Journal:  Eur Radiol       Date:  2004-03-09       Impact factor: 5.315

5.  Current status of therapy for hepatocellular carcinoma.

Authors:  Kathleen E Corey; Daniel S Pratt
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

6.  Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning.

Authors:  Hong Zhao; Jin-Lin Yao; Ying Wang; Kang-Rong Zhou
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

7.  Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling.

Authors:  Tong San Koh; Choon Hua Thng; Septian Hartono; Puor Sherng Lee; Su Pin Choo; Donald Y H Poon; Han Chong Toh; Sotirios Bisdas
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

Review 8.  Multistep human hepatocarcinogenesis: correlation of imaging with pathology.

Authors:  Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging.

Authors:  Rieko Shinmura; Osamu Matsui; Masumi Kadoya; Satoshi Kobayashi; Noboru Terayama; Junichiro Sanada; Hiroshi Demachi; Toshifumi Gabata
Journal:  Eur Radiol       Date:  2008-04-02       Impact factor: 5.315

10.  Favorable surgical outcomes in patients with early hepatocellular carcinoma.

Authors:  Masakazu Yamamoto; Ken Takasaki; Takehito Otsubo; Hideo Katsuragawa; Satoshi Katagiri; Kenji Yoshitoshi; Shunichi Ariizumi; Akiko Saito; Masayuki Nakano
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.